miR-21 and miR-181b promotes MDSCs generation by targeting STAT3 and C/EBP in sepsis-induced inflammatory response, while when inhibiting these miRNAs, the number of MDSCs is reduced and the late-sepsis survival was significantly enhanced (56). The gene discussed is STAT3; the disease is Sepsis.